NDC11_format|NDC11_unformat|NDC10_format|NDC10_unformat|desc|tradename 00005-0100-01|00005010001|0005-0100-01|0005010001|meningococcal group B vaccine|Trumenba 00005-0100-02|00005010002|0005-0100-02|0005010002|meningococcal group B vaccine|Trumenba 00005-0100-05|00005010005|0005-0100-05|0005010005|meningococcal group B vaccine|Trumenba 00005-0100-10|00005010010|0005-0100-10|0005010010|meningococcal group B vaccine|Trumenba 00005-1970-49|00005197049|0005-1970-49|0005197049|Pneumococcal 7-valent|Prevnar 00005-1970-50|00005197050|0005-1970-50|0005197050|Pneumococcal 7-valent|Prevnar 00005-1971-01|00005197101|0005-1971-01|0005197101|pneumococcal 13-valent conjugate vaccine|PREVNAR 13 00005-1971-02|00005197102|0005-1971-02|0005197102|pneumococcal 13-valent conjugate vaccine|PREVNAR 13 00005-1971-04|00005197104|0005-1971-04|0005197104|pneumococcal 13-valent conjugate vaccine|PREVNAR 13 00005-1971-05|00005197105|0005-1971-05|0005197105|pneumococcal 13-valent conjugate vaccine|PREVNAR 13 00005-2000-01|00005200001|0005-2000-01|0005200001|Pneumococcal 20-valent Conjugate Vaccine|Prevnar 20 00005-2000-02|00005200002|0005-2000-02|0005200002|Pneumococcal 20-valent Conjugate Vaccine|Prevnar 20 00005-2000-10|00005200010|0005-2000-10|0005200010|Pneumococcal 20-valent Conjugate Vaccine|Prevnar 20 00006-4045-00|00006404500|0006-4045-00|0006404500|Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant|GARDASIL 00006-4045-01|00006404501|0006-4045-01|0006404501|Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant|GARDASIL 00006-4045-41|00006404541|0006-4045-41|0006404541|Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant|GARDASIL 00006-4047-01|00006404701|0006-4047-01|0006404701|Rotavirus Vaccine, Live, Oral, Pentavalent|RotaTeq 00006-4047-02|00006404702|0006-4047-02|0006404702|Rotavirus Vaccine, Live, Oral, Pentavalent|RotaTeq 00006-4047-20|00006404720|0006-4047-20|0006404720|Rotavirus Vaccine, Live, Oral, Pentavalent|RotaTeq 00006-4047-41|00006404741|0006-4047-41|0006404741|Rotavirus Vaccine, Live, Oral, Pentavalent|RotaTeq 00006-4093-01|00006409301|0006-4093-01|0006409301|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4093-02|00006409302|0006-4093-02|0006409302|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4093-09|00006409309|0006-4093-09|0006409309|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4094-01|00006409401|0006-4094-01|0006409401|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4094-02|00006409402|0006-4094-02|0006409402|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4094-09|00006409409|0006-4094-09|0006409409|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4095-01|00006409501|0006-4095-01|0006409501|hepatitis A vaccine, inactivated|VAQTA 00006-4095-02|00006409502|0006-4095-02|0006409502|hepatitis A vaccine, inactivated|VAQTA 00006-4095-09|00006409509|0006-4095-09|0006409509|hepatitis A vaccine, inactivated|VAQTA 00006-4096-01|00006409601|0006-4096-01|0006409601|hepatitis A vaccine, inactivated|VAQTA 00006-4096-02|00006409602|0006-4096-02|0006409602|hepatitis A vaccine, inactivated|VAQTA 00006-4096-09|00006409609|0006-4096-09|0006409609|hepatitis A vaccine, inactivated|VAQTA 00006-4109-01|00006410901|0006-4109-01|0006410901|Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant|GARDASIL 00006-4109-02|00006410902|0006-4109-02|0006410902|Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant|GARDASIL 00006-4109-09|00006410909|0006-4109-09|0006410909|Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant|GARDASIL 00006-4119-01|00006411901|0006-4119-01|0006411901|Human Papillomavirus 9-valent Vaccine, Recombinant|GARDASIL 9 00006-4119-02|00006411902|0006-4119-02|0006411902|Human Papillomavirus 9-valent Vaccine, Recombinant|GARDASIL 9 00006-4119-03|00006411903|0006-4119-03|0006411903|Human Papillomavirus 9-valent Vaccine, Recombinant|GARDASIL 9 00006-4121-01|00006412101|0006-4121-01|0006412101|Human Papillomavirus 9-valent Vaccine, Recombinant|GARDASIL 9 00006-4121-02|00006412102|0006-4121-02|0006412102|Human Papillomavirus 9-valent Vaccine, Recombinant|GARDASIL 9 00006-4133-01|00006413301|0006-4133-01|0006413301|Tetanus and Diphtheria Toxoids Adsorbed|Tetanus and Diphtheria Toxoids Adsorbed 00006-4133-41|00006413341|0006-4133-41|0006413341|Tetanus and Diphtheria Toxoids Adsorbed|Tetanus and Diphtheria Toxoids Adsorbed 00006-4171-00|00006417100|0006-4171-00|0006417100|Measles, Mumps, Rubella and Varicella Virus Vaccine Live|ProQuad 00006-4171-01|00006417101|0006-4171-01|0006417101|Measles, Mumps, Rubella and Varicella Virus Vaccine Live|ProQuad 00006-4293-01|00006429301|0006-4293-01|0006429301|ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN|ERVEBO 00006-4293-02|00006429302|0006-4293-02|0006429302|ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN|ERVEBO 00006-4329-01|00006432901|0006-4329-01|0006432901|Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed|VAXNEUVANCE 00006-4329-02|00006432902|0006-4329-02|0006432902|Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed|VAXNEUVANCE 00006-4329-03|00006432903|0006-4329-03|0006432903|Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed|VAXNEUVANCE 00006-4681-00|00006468100|0006-4681-00|0006468100|measles, mumps, and rubella virus vaccine live|M-M-R II 00006-4681-01|00006468101|0006-4681-01|0006468101|measles, mumps, and rubella virus vaccine live|M-M-R II 00006-4739-00|00006473900|0006-4739-00|0006473900|pneumococcal vaccine polyvalent|PNEUMOVAX 23 00006-4739-01|00006473901|0006-4739-01|0006473901|pneumococcal vaccine polyvalent|PNEUMOVAX 23 00006-4826-00|00006482600|0006-4826-00|0006482600|Varicella Virus Vaccine Live|VARIVAX 00006-4826-01|00006482601|0006-4826-01|0006482601|Varicella Virus Vaccine Live|VARIVAX 00006-4827-00|00006482700|0006-4827-00|0006482700|Varicella Virus Vaccine Live|VARIVAX 00006-4827-01|00006482701|0006-4827-01|0006482701|Varicella Virus Vaccine Live|VARIVAX 00006-4831-01|00006483101|0006-4831-01|0006483101|hepatitis A vaccine, inactivated|VAQTA 00006-4831-41|00006483141|0006-4831-41|0006483141|hepatitis A vaccine, inactivated|VAQTA 00006-4837-01|00006483701|0006-4837-01|0006483701|pneumococcal vaccine polyvalent|PNEUMOVAX 23 00006-4837-02|00006483702|0006-4837-02|0006483702|pneumococcal vaccine polyvalent|PNEUMOVAX 23 00006-4837-03|00006483703|0006-4837-03|0006483703|pneumococcal vaccine polyvalent|PNEUMOVAX 23 00006-4841-00|00006484100|0006-4841-00|0006484100|hepatitis A vaccine, inactivated|VAQTA 00006-4841-01|00006484101|0006-4841-01|0006484101|hepatitis A vaccine, inactivated|VAQTA 00006-4841-41|00006484141|0006-4841-41|0006484141|hepatitis A vaccine, inactivated|VAQTA 00006-4897-00|00006489700|0006-4897-00|0006489700|Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)|PedvaxHIB 00006-4897-01|00006489701|0006-4897-01|0006489701|Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)|PedvaxHIB 00006-4898-00|00006489800|0006-4898-00|0006489800|Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine|COMVAX 00006-4898-01|00006489801|0006-4898-01|0006489801|Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine|COMVAX 00006-4943-00|00006494300|0006-4943-00|0006494300|pneumococcal vaccine polyvalent|PNEUMOVAX 23 00006-4943-01|00006494301|0006-4943-01|0006494301|pneumococcal vaccine polyvalent|PNEUMOVAX 23 00006-4963-00|00006496300|0006-4963-00|0006496300|Zoster Vaccine Live|ZOSTAVAX 00006-4963-01|00006496301|0006-4963-01|0006496301|Zoster Vaccine Live|ZOSTAVAX 00006-4963-41|00006496341|0006-4963-41|0006496341|Zoster Vaccine Live|ZOSTAVAX 00006-4980-00|00006498000|0006-4980-00|0006498000|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4981-00|00006498100|0006-4981-00|0006498100|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4981-01|00006498101|0006-4981-01|0006498101|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4992-00|00006499200|0006-4992-00|0006499200|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4992-01|00006499201|0006-4992-01|0006499201|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4995-00|00006499500|0006-4995-00|0006499500|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4995-01|00006499501|0006-4995-01|0006499501|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4995-41|00006499541|0006-4995-41|0006499541|Hepatitis B Vaccine (Recombinant)|RECOMBIVAX HB 00006-4999-00|00006499900|0006-4999-00|0006499900|Measles, Mumps, Rubella and Varicella Virus Vaccine Live|ProQuad 00006-4999-01|00006499901|0006-4999-01|0006499901|Measles, Mumps, Rubella and Varicella Virus Vaccine Live|ProQuad 00052-0603-01|00052060301|0052-0603-01|0052060301|BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN|BCG VACCINE 00052-0603-02|00052060302|0052-0603-02|0052060302|BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN|BCG VACCINE 00069-0207-01|00069020701|0069-0207-01|0069020701|Respiratory Syncytial Virus Vaccine|Abrysvo 00069-0271-01|00069027101|0069-0271-01|0069027101|meningococcal groups a, b, c, w, and y vaccine|PENBRAYA 00069-0297-01|00069029701|0069-0297-01|0069029701|Tick-Borne Encephalitis Vaccine|TicoVac 00069-0297-02|00069029702|0069-0297-02|0069029702|Tick-Borne Encephalitis Vaccine|TicoVac 00069-0297-10|00069029710|0069-0297-10|0069029710|Tick-Borne Encephalitis Vaccine|TicoVac 00069-0332-01|00069033201|0069-0332-01|0069033201|meningococcal groups a, b, c, w, and y vaccine|PENBRAYA 00069-0344-01|00069034401|0069-0344-01|0069034401|Respiratory Syncytial Virus Vaccine|Abrysvo 00069-0344-05|00069034405|0069-0344-05|0069034405|Respiratory Syncytial Virus Vaccine|Abrysvo 00069-0344-10|00069034410|0069-0344-10|0069034410|Respiratory Syncytial Virus Vaccine|Abrysvo 00069-0411-01|00069041101|0069-0411-01|0069041101|Tick-Borne Encephalitis Vaccine|TicoVac 00069-0411-02|00069041102|0069-0411-02|0069041102|Tick-Borne Encephalitis Vaccine|TicoVac 00069-0411-10|00069041110|0069-0411-10|0069041110|Tick-Borne Encephalitis Vaccine|TicoVac 00069-0600-01|00069060001|0069-0600-01|0069060001|meningococcal groups a, b, c, w, and y vaccine|PENBRAYA 00069-0600-05|00069060005|0069-0600-05|0069060005|meningococcal groups a, b, c, w, and y vaccine|PENBRAYA 00069-0600-10|00069060010|0069-0600-10|0069060010|meningococcal groups a, b, c, w, and y vaccine|PENBRAYA 00069-2025-01|00069202501|0069-2025-01|0069202501|COVID-19 Vaccine, mRNA|Comirnaty 00069-2025-10|00069202510|0069-2025-10|0069202510|COVID-19 Vaccine, mRNA|Comirnaty 00069-2025-25|00069202525|0069-2025-25|0069202525|COVID-19 Vaccine, mRNA|Comirnaty 00069-2362-01|00069236201|0069-2362-01|0069236201|COVID-19 Vaccine, mRNA|Comirnaty 00069-2362-10|00069236210|0069-2362-10|0069236210|COVID-19 Vaccine, mRNA|Comirnaty 00069-2377-01|00069237701|0069-2377-01|0069237701|COVID-19 Vaccine, mRNA|Comirnaty 00069-2377-10|00069237710|0069-2377-10|0069237710|COVID-19 Vaccine, mRNA|Comirnaty 00069-2392-01|00069239201|0069-2392-01|0069239201|COVID-19 Vaccine, mRNA|Comirnaty 00069-2392-10|00069239210|0069-2392-10|0069239210|COVID-19 Vaccine, mRNA|Comirnaty 00310-1222-10|00310122210|0310-1222-10|0310122210|AZD1222|ASTRAZENECA COVID-19 VACCINE 00310-1222-15|00310122215|0310-1222-15|0310122215|AZD1222|ASTRAZENECA COVID-19 VACCINE 13533-0131-00|13533013100|13533-131-00|1353313100|tetanus and diphtheria toxoids adsorbed|TDVAX 13533-0131-01|13533013101|13533-131-01|1353313101|tetanus and diphtheria toxoids adsorbed|TDVAX 14362-0111-03|14362011103|14362-0111-3|1436201113|Tetanus and Diphtheria Toxoids Adsorbed|TDVAX 14362-0111-04|14362011104|14362-0111-4|1436201114|Tetanus and Diphtheria Toxoids Adsorbed|TDVAX 17478-0131-00|17478013100|17478-131-00|1747813100|Tetanus and Diphtheria Toxoids Adsorbed|Tetanus and Diphtheria Toxoids Adsorbed 17478-0131-01|17478013101|17478-131-01|1747813101|Tetanus and Diphtheria Toxoids Adsorbed|Tetanus and Diphtheria Toxoids Adsorbed 19515-0808-41|19515080841|19515-808-41|1951580841|influenza virus vaccine|Flulaval Quadrivalent 19515-0808-52|19515080852|19515-808-52|1951580852|influenza virus vaccine|Flulaval Quadrivalent 19515-0814-41|19515081441|19515-814-41|1951581441|influenza virus vaccine|Flulaval Quadrivalent 19515-0814-52|19515081452|19515-814-52|1951581452|influenza virus vaccine|Flulaval Quadrivalent 19515-0816-41|19515081641|19515-816-41|1951581641|influenza virus vaccine|Flulaval Quadrivalent 19515-0816-52|19515081652|19515-816-52|1951581652|influenza virus vaccine|Flulaval Quadrivalent 19515-0818-41|19515081841|19515-818-41|1951581841|influenza virus vaccine|Flulaval Quadrivalent 19515-0818-52|19515081852|19515-818-52|1951581852|influenza virus vaccine|Flulaval Quadrivalent 19515-0845-01|19515084501|19515-845-01|1951584501|Influenza Vaccine(Suspension for Intramuscular Injection; 2015-2016 Formula)|FLULAVAL 19515-0845-11|19515084511|19515-845-11|1951584511|Influenza Vaccine(Suspension for Intramuscular Injection;2015-2016 Formula)|FLULAVAL 19515-0850-41|19515085041|19515-850-41|1951585041|Influenza Vaccine(Suspension for Intramuscular Injection;2015-2016 Formula)|FLULAVAL 19515-0850-52|19515085052|19515-850-52|1951585052|Influenza Vaccine(Suspension for Intramuscular Injection;2015-2016 Formula)|FLULAVAL 19515-0889-02|19515088902|19515-889-02|1951588902|influenza virus vaccine|FLULAVAL 19515-0889-07|19515088907|19515-889-07|1951588907|influenza virus vaccine|FLULAVAL 19515-0890-02|19515089002|19515-890-02|1951589002|influenza virus vaccine|FLULAVAL 19515-0890-07|19515089007|19515-890-07|1951589007|influenza virus vaccine|FLULAVAL 19515-0891-01|19515089101|19515-891-01|1951589101|influenza virus vaccine|Flulaval Quadrivalent 19515-0891-11|19515089111|19515-891-11|1951589111|influenza virus vaccine|Flulaval Quadrivalent 19515-0893-02|19515089302|19515-893-02|1951589302|influenza virus vaccine|FLULAVAL 19515-0893-07|19515089307|19515-893-07|1951589307|influenza virus vaccine|FLULAVAL 19515-0894-41|19515089441|19515-894-41|1951589441|influenza virus vaccine|Flulaval Quadrivalent 19515-0894-52|19515089452|19515-894-52|1951589452|influenza virus vaccine|Flulaval Quadrivalent 19515-0895-01|19515089501|19515-895-01|1951589501|influenza virus vaccine|Flulaval Quadrivalent 19515-0895-11|19515089511|19515-895-11|1951589511|influenza virus vaccine|Flulaval Quadrivalent 19515-0896-01|19515089601|19515-896-01|1951589601|influenza virus vaccine|Flulaval Quadrivalent 19515-0896-11|19515089611|19515-896-11|1951589611|influenza virus vaccine|Flulaval Quadrivalent 19515-0897-01|19515089701|19515-897-01|1951589701|influenza virus vaccine|Flulaval Quadrivalent 19515-0897-11|19515089711|19515-897-11|1951589711|influenza virus vaccine|Flulaval Quadrivalent 19515-0898-01|19515089801|19515-898-01|1951589801|influenza virus vaccine|Flulaval Quadrivalent 19515-0898-11|19515089811|19515-898-11|1951589811|influenza virus vaccine|Flulaval Quadrivalent 19515-0900-01|19515090001|19515-900-01|1951590001|influenza virus vaccine|Flulaval Quadrivalent 19515-0900-11|19515090011|19515-900-11|1951590011|influenza virus vaccine|Flulaval Quadrivalent 19515-0901-41|19515090141|19515-901-41|1951590141|influenza virus vaccine|Flulaval Quadrivalent 19515-0901-52|19515090152|19515-901-52|1951590152|influenza virus vaccine|Flulaval Quadrivalent 19515-0903-01|19515090301|19515-903-01|1951590301|influenza virus vaccine|Flulaval Quadrivalent 19515-0903-11|19515090311|19515-903-11|1951590311|influenza virus vaccine|Flulaval Quadrivalent 19515-0906-41|19515090641|19515-906-41|1951590641|influenza virus vaccine|Flulaval Quadrivalent 19515-0906-52|19515090652|19515-906-52|1951590652|influenza virus vaccine|Flulaval Quadrivalent 19515-0908-41|19515090841|19515-908-41|1951590841|influenza virus vaccine|Flulaval Quadrivalent 19515-0908-52|19515090852|19515-908-52|1951590852|influenza virus vaccine|Flulaval Quadrivalent 19515-0909-41|19515090941|19515-909-41|1951590941|influenza virus vaccine|Flulaval Quadrivalent 19515-0909-52|19515090952|19515-909-52|1951590952|influenza virus vaccine|Flulaval Quadrivalent 19515-0912-41|19515091241|19515-912-41|1951591241|influenza virus vaccine|Flulaval Quadrivalent 19515-0912-52|19515091252|19515-912-52|1951591252|influenza virus vaccine|Flulaval Quadrivalent 21695-0413-01|21695041301|21695-413-01|2169541301|Tetanus and Diphtheria Toxoids Adsorbed|Tetanus and Diphtheria Toxoids Adsorbed 33332-0010-01|33332001001|33332-010-01|3333201001|Influenza Virus Vaccine A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)(Suspension for Intramuscular Injection; 2010-2011 Formula)|AFLURIA 33332-0013-01|33332001301|33332-013-01|3333201301|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0013-02|33332001302|33332-013-02|3333201302|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0014-01|33332001401|33332-014-01|3333201401|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0014-02|33332001402|33332-014-02|3333201402|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0015-01|33332001501|33332-015-01|3333201501|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0015-02|33332001502|33332-015-02|3333201502|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0016-01|33332001601|33332-016-01|3333201601|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0016-02|33332001602|33332-016-02|3333201602|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0017-01|33332001701|33332-017-01|3333201701|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), AND INFLUENZA B VIRUS B/BRISBANE/46/2015 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0017-02|33332001702|33332-017-02|3333201702|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), AND INFLUENZA B VIRUS B/BRISBANE/46/2015 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0018-01|33332001801|33332-018-01|3333201801|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) AND INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0018-02|33332001802|33332-018-02|3333201802|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) AND INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0110-10|33332011010|33332-110-10|3333211010|Influenza Virus Vaccine A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)(Suspension for Intramuscular Injection;2010-2011 Formula)|AFLURIA 33332-0113-10|33332011310|33332-113-10|3333211310|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0113-11|33332011311|33332-113-11|3333211311|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0114-10|33332011410|33332-114-10|3333211410|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0114-11|33332011411|33332-114-11|3333211411|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0115-10|33332011510|33332-115-10|3333211510|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0115-11|33332011511|33332-115-11|3333211511|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0116-10|33332011610|33332-116-10|3333211610|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0116-11|33332011611|33332-116-11|3333211611|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0117-10|33332011710|33332-117-10|3333211710|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), AND INFLUENZA B VIRUS B/BRISBANE/46/2015 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0117-11|33332011711|33332-117-11|3333211711|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), AND INFLUENZA B VIRUS B/BRISBANE/46/2015 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0118-10|33332011810|33332-118-10|3333211810|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) AND INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0118-11|33332011811|33332-118-11|3333211811|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) AND INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA 33332-0219-20|33332021920|33332-219-20|3333221920|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0219-21|33332021921|33332-219-21|3333221921|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0220-20|33332022020|33332-220-20|3333222020|INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0220-21|33332022021|33332-220-21|3333222021|INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0221-20|33332022120|33332-221-20|3333222120|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/CAMBODIA/E0826360/2020 IVR-224 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0221-21|33332022121|33332-221-21|3333222121|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/CAMBODIA/E0826360/2020 IVR-224 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0316-01|33332031601|33332-316-01|3333231601|Influenza Virus Vaccine (Inactivated) for influenza A subtype viruses and type B viruses (2016-2017 Formula)|AFLURIA QUADRIVALENT 33332-0316-02|33332031602|33332-316-02|3333231602|Influenza vaccine (Inactivated)for influenza A subtype viruses and type B viruses (2016-2017)|AFLURIA QUADRIVALENT 33332-0317-01|33332031701|33332-317-01|3333231701|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/BRISBANE/46/2015 ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA QUADRIVALENT 33332-0317-02|33332031702|33332-317-02|3333231702|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/BRISBANE/46/2015 ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA QUADRIVALENT 33332-0318-01|33332031801|33332-318-01|3333231801|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), AND INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA QUADRIVALENT 33332-0318-02|33332031802|33332-318-02|3333231802|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), AND INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA QUADRIVALENT 33332-0319-01|33332031901|33332-319-01|3333231901|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0319-02|33332031902|33332-319-02|3333231902|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0320-01|33332032001|33332-320-01|3333232001|INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0320-02|33332032002|33332-320-02|3333232002|INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0321-01|33332032101|33332-321-01|3333232101|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/CAMBODIA/E0826360/2020 IVR-224 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0321-02|33332032102|33332-321-02|3333232102|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/CAMBODIA/E0826360/2020 IVR-224 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0322-03|33332032203|33332-322-03|3333232203|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0322-04|33332032204|33332-322-04|3333232204|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0323-03|33332032303|33332-323-03|3333232303|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0323-04|33332032304|33332-323-04|3333232304|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0416-10|33332041610|33332-416-10|3333241610|Influenza vaccine (Inactivated)for influenza A subtype viruses and type B viruses (2016-2017)|AFLURIA QUADRIVALENT 33332-0416-11|33332041611|33332-416-11|3333241611|Influenza vaccine (Inactivated)for influenza A subtype viruses and type B viruses (2016-2017)|AFLURIA QUADRIVALENT 33332-0417-10|33332041710|33332-417-10|3333241710|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/BRISBANE/46/2015 ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA QUADRIVALENT 33332-0417-11|33332041711|33332-417-11|3333241711|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/BRISBANE/46/2015 ANTIGEN (PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA QUADRIVALENT 33332-0418-10|33332041810|33332-418-10|3333241810|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), AND INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA QUADRIVALENT 33332-0418-11|33332041811|33332-418-11|3333241811|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), AND INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|AFLURIA QUADRIVALENT 33332-0419-10|33332041910|33332-419-10|3333241910|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0419-11|33332041911|33332-419-11|3333241911|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0420-10|33332042010|33332-420-10|3333242010|INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0420-11|33332042011|33332-420-11|3333242011|INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0421-10|33332042110|33332-421-10|3333242110|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/CAMBODIA/E0826360/2020 IVR-224 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0421-11|33332042111|33332-421-11|3333242111|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/CAMBODIA/E0826360/2020 IVR-224 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0422-10|33332042210|33332-422-10|3333242210|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0422-11|33332042211|33332-422-11|3333242211|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0423-10|33332042310|33332-423-10|3333242310|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0423-11|33332042311|33332-423-11|3333242311|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)|Afluria Quadrivalent 33332-0519-01|33332051901|33332-519-01|3333251901|Influenza A (H1N1) 2009 Monovalent Vaccine|Influenza A 33332-0519-25|33332051925|33332-519-25|3333251925|Influenza A (H1N1) 2009 Monovalent Vaccine|Influenza A 33332-0629-10|33332062910|33332-629-10|3333262910|Influenza A (H1N1) 2009 Monovalent Vaccine|Influenza A 42515-0001-00|42515000100|42515-001-00|4251500100|Japanese Encephalitis Vaccine, Inactivated, Adsorbed|IXIARO 42515-0001-01|42515000101|42515-001-01|4251500101|Japanese Encephalitis Vaccine, Inactivated, Adsorbed|IXIARO 42515-0002-01|42515000201|42515-002-01|4251500201|Japanese Encephalitis Vaccine, Inactivated, Adsorbed|IXIARO 42515-0003-00|42515000300|42515-003-00|4251500300|Chikungunya Vaccine, Live-Attenuated|IXCHIQ 42515-0003-01|42515000301|42515-003-01|4251500301|Chikungunya Vaccine, Live-Attenuated|IXCHIQ 42874-0012-01|42874001201|42874-012-01|4287401201|Influenza Vaccine|Flublok 42874-0012-10|42874001210|42874-012-10|4287401210|Influenza Vaccine|Flublok 42874-0013-01|42874001301|42874-013-01|4287401301|Influenza Vaccine|Flublok 42874-0013-10|42874001310|42874-013-10|4287401310|Influenza Vaccine|Flublok 42874-0014-01|42874001401|42874-014-01|4287401401|Influenza Vaccine|Flublok 42874-0014-10|42874001410|42874-014-10|4287401410|Influenza Vaccine|Flublok 42874-0015-01|42874001501|42874-015-01|4287401501|Influenza Vaccine|Flublok 42874-0015-10|42874001510|42874-015-10|4287401510|Influenza Vaccine|Flublok 42874-0016-01|42874001601|42874-016-01|4287401601|Influenza Vaccine|Flublok 42874-0016-10|42874001610|42874-016-10|4287401610|Influenza Vaccine|Flublok 42874-0017-01|42874001701|42874-017-01|4287401701|Influenza Vaccine|Flublok 42874-0017-10|42874001710|42874-017-10|4287401710|Influenza Vaccine|Flublok 42874-0117-01|42874011701|42874-117-01|4287411701|influenza vaccine|Flublok Quadrivalent 42874-0117-10|42874011710|42874-117-10|4287411710|influenza vaccine|Flublok Quadrivalent 43528-0002-01|43528000201|43528-002-01|4352800201|Hepatitis B Vaccine (Recombinant) Adjuvanted|HEPLISAV-B 43528-0002-05|43528000205|43528-002-05|4352800205|Hepatitis B Vaccine (Recombinant) Adjuvanted|HEPLISAV-B 43528-0003-01|43528000301|43528-003-01|4352800301|Hepatitis B Vaccine (Recombinant) Adjuvanted|HEPLISAV-B 43528-0003-05|43528000305|43528-003-05|4352800305|Hepatitis B Vaccine (Recombinant) Adjuvanted|HEPLISAV-B 46028-0114-01|46028011401|46028-114-01|4602811401|NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN|Bexsero 46028-0114-02|46028011402|46028-114-02|4602811402|NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN|Bexsero 46028-0114-11|46028011411|46028-114-11|4602811411|NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN|Bexsero 46028-0208-01|46028020801|46028-208-01|4602820801|Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine|Menveo 46028-0218-11|46028021811|46028-218-11|4602821811|Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine|Menveo 46028-0219-11|46028021911|46028-219-11|4602821911|Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine|Menveo 49281-0010-10|49281001010|49281-010-10|4928101010|Influenza Virus Vaccine a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated),b virus b/brisbane/60/2008 antigen (formaldehyde inactivated),(Suspension for Intramuscular Injection;2010-2011 Formula)|FLUZONE 49281-0010-25|49281001025|49281-010-25|4928101025|Influenza Virus Vaccine a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated)(Suspension for Intramuscular Injection;2010-2011 Formula)|FLUZONE 49281-0010-50|49281001050|49281-010-50|4928101050|Influenza Virus Vaccine a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated) (Suspension for Intramuscular Injection;2010-2011 Formula)|FLUZONE 49281-0011-10|49281001110|49281-011-10|4928101110|Influenza Virus Vaccine(Suspension for Injection;2011-2012 Formula)|FLUZONE 49281-0011-50|49281001150|49281-011-50|4928101150|Influenza Virus Vaccine a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated)(Suspension for Injection;2011-2012 Formula)|FLUZONE 49281-0012-10|49281001210|49281-012-10|4928101210|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TEXAS/6/2011 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0012-50|49281001250|49281-012-50|4928101250|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TEXAS/6/2011 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0013-10|49281001310|49281-013-10|4928101310|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0013-50|49281001350|49281-013-50|4928101350|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0013-58|49281001358|49281-013-58|4928101358|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0013-88|49281001388|49281-013-88|4928101388|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0014-50|49281001450|49281-014-50|4928101450|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0014-88|49281001488|49281-014-88|4928101488|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0111-25|49281011125|49281-111-25|4928111125|Influenza Virus Vaccine a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated)(Suspension for Injection;2011-2012 Formula)|FLUZONE 49281-0112-25|49281011225|49281-112-25|4928111225|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TEXAS/6/2011 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0113-00|49281011300|49281-113-00|4928111300|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0113-25|49281011325|49281-113-25|4928111325|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0120-65|49281012065|49281-120-65|4928112065|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Northern Hemisphere 49281-0120-88|49281012088|49281-120-88|4928112088|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Northern Hemisphere 49281-0121-65|49281012165|49281-121-65|4928112165|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Northern Hemisphere 49281-0121-88|49281012188|49281-121-88|4928112188|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Northern Hemisphere 49281-0122-65|49281012265|49281-122-65|4928112265|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Northern Hemisphere 49281-0122-88|49281012288|49281-122-88|4928112288|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Northern Hemisphere 49281-0123-65|49281012365|49281-123-65|4928112365|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|Fluzone High-Dose Quadrivalent Northern Hemisphere 49281-0123-88|49281012388|49281-123-88|4928112388|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|Fluzone High-Dose Quadrivalent Northern Hemisphere 49281-0181-00|49281018100|49281-181-00|4928118100|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SOUTH AUSTRALIA/34/2019 IVR-197 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0181-25|49281018125|49281-181-25|4928118125|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SOUTH AUSTRALIA/34/2019 IVR-197 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0182-00|49281018200|49281-182-00|4928118200|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Hong Kong/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0182-25|49281018225|49281-182-25|4928118225|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Hong Kong/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0215-10|49281021510|49281-215-10|4928121510|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|TENIVAC 49281-0215-15|49281021515|49281-215-15|4928121515|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|TENIVAC 49281-0215-58|49281021558|49281-215-58|4928121558|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|TENIVAC 49281-0215-88|49281021588|49281-215-88|4928121588|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|TENIVAC 49281-0225-10|49281022510|49281-225-10|4928122510|CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|DIPHTHERIA AND TETANUS TOXOIDS ADSORBED 49281-0225-58|49281022558|49281-225-58|4928122558|CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|DIPHTHERIA AND TETANUS TOXOIDS ADSORBED 49281-0246-58|49281024658|49281-246-58|4928124658|RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) and WATER|IMOVAX RABIES 49281-0248-58|49281024858|49281-248-58|4928124858|RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) and WATER|IMOVAX RABIES 49281-0250-51|49281025051|49281-250-51|4928125051|RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) and WATER|IMOVAX RABIES 49281-0252-51|49281025251|49281-252-51|4928125251|RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) and WATER|IMOVAX RABIES 49281-0278-10|49281027810|49281-278-10|4928127810|Diphtheria and Tetanus Toxoids Adsorbed USP (For Pediatric Use) (DT), for intramuscular use (DT)|DIPHTHERIA AND TETANUS TOXOIDS ADSORBED 49281-0286-01|49281028601|49281-286-01|4928128601|corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen|DAPTACEL 49281-0286-05|49281028605|49281-286-05|4928128605|corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen|DAPTACEL 49281-0286-10|49281028610|49281-286-10|4928128610|corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen|DAPTACEL 49281-0286-58|49281028658|49281-286-58|4928128658|corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen|DAPTACEL 49281-0291-10|49281029110|49281-291-10|4928129110|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|DECAVAC 49281-0291-83|49281029183|49281-291-83|4928129183|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|DECAVAC 49281-0298-10|49281029810|49281-298-10|4928129810|Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP), for intramuscular use (DTaP)|TRIPEDIA 49281-0320-50|49281032050|49281-320-50|4928132050|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SOUTH AUSTRALIA/34/2019 IVR-197 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0320-88|49281032088|49281-320-88|4928132088|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SOUTH AUSTRALIA/34/2019 IVR-197 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0321-50|49281032150|49281-321-50|4928132150|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Hong Kong/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0321-88|49281032188|49281-321-88|4928132188|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Hong Kong/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0322-50|49281032250|49281-322-50|4928132250|INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0322-88|49281032288|49281-322-88|4928132288|INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0323-50|49281032350|49281-323-50|4928132350|INFLUENZA A VIRUS A/Sydney/5/2021 SAN-013 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0323-88|49281032388|49281-323-88|4928132388|INFLUENZA A VIRUS A/Sydney/5/2021 SAN-013 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0324-50|49281032450|49281-324-50|4928132450|INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CALIFORNIA/122/2022 (A/THAILAND/8/2022-LIKE VIRUS (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0324-88|49281032488|49281-324-88|4928132488|INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CALIFORNIA/122/2022 (A/THAILAND/8/2022-LIKE VIRUS (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0336-15|49281033615|49281-336-15|4928133615|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SOUTH AUSTRALIA/34/2019 IVR-197 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0336-78|49281033678|49281-336-78|4928133678|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SOUTH AUSTRALIA/34/2019 IVR-197 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0337-15|49281033715|49281-337-15|4928133715|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Hong Kong/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0337-78|49281033778|49281-337-78|4928133778|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Hong Kong/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0339-15|49281033915|49281-339-15|4928133915|INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0339-78|49281033978|49281-339-78|4928133978|INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0355-15|49281035515|49281-355-15|4928135515|INFLUENZA A VIRUS A/Sydney/5/2021 SAN-013 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0355-78|49281035578|49281-355-78|4928135578|INFLUENZA A VIRUS A/Sydney/5/2021 SAN-013 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0379-50|49281037950|49281-379-50|4928137950|INFLUENZA A VIRUS A/SYDNEY/5/2021 SAN-013 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Darwin/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/Michigan/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Southern Hemisphere 49281-0379-88|49281037988|49281-379-88|4928137988|INFLUENZA A VIRUS A/SYDNEY/5/2021 SAN-013 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Darwin/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/Michigan/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Southern Hemisphere 49281-0386-15|49281038615|49281-386-15|4928138615|Influenza Virus Vaccine a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated)(Suspension for Injection;2010-2011 Formula)|FLUZONE 49281-0387-65|49281038765|49281-387-65|4928138765|Influenza Virus Vaccine a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated)(Suspension for Injection;2010-2011 Formula)|FLUZONE 49281-0388-15|49281038815|49281-388-15|4928138815|Influenza Virus Vaccine(Suspension for Injection;2011-2012 Formula)|FLUZONE 49281-0389-65|49281038965|49281-389-65|4928138965|Influenza Virus Vaccine a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated)(Suspension for Injection;2011-2012 Formula)|FLUZONE HIGH DOSE 49281-0390-15|49281039015|49281-390-15|4928139015|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TEXAS/6/2011 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0391-65|49281039165|49281-391-65|4928139165|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TEXAS/6/2011 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0392-15|49281039215|49281-392-15|4928139215|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0392-78|49281039278|49281-392-78|4928139278|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0393-65|49281039365|49281-393-65|4928139365|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0393-88|49281039388|49281-393-88|4928139388|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0394-15|49281039415|49281-394-15|4928139415|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0394-78|49281039478|49281-394-78|4928139478|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0395-65|49281039565|49281-395-65|4928139565|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0395-88|49281039588|49281-395-88|4928139588|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0396-15|49281039615|49281-396-15|4928139615|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0396-78|49281039678|49281-396-78|4928139678|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0397-65|49281039765|49281-397-65|4928139765|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0397-88|49281039788|49281-397-88|4928139788|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0398-15|49281039815|49281-398-15|4928139815|INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CALIFORNIA/122/2022 (A/THAILAND/8/2022-LIKE VIRUS (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0398-78|49281039878|49281-398-78|4928139878|INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CALIFORNIA/122/2022 (A/THAILAND/8/2022-LIKE VIRUS (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE 49281-0399-65|49281039965|49281-399-65|4928139965|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0399-88|49281039988|49281-399-88|4928139988|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0400-05|49281040005|49281-400-05|4928140005|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN|Adacel 49281-0400-10|49281040010|49281-400-10|4928140010|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN|Adacel 49281-0400-15|49281040015|49281-400-15|4928140015|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN|Adacel 49281-0400-20|49281040020|49281-400-20|4928140020|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN|Adacel 49281-0400-58|49281040058|49281-400-58|4928140058|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN|Adacel 49281-0400-88|49281040088|49281-400-88|4928140088|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN|Adacel 49281-0400-89|49281040089|49281-400-89|4928140089|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN|Adacel 49281-0401-65|49281040165|49281-401-65|4928140165|INFLUENZA A VIRUSA/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0401-88|49281040188|49281-401-88|4928140188|INFLUENZA A VIRUSA/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose 49281-0403-65|49281040365|49281-403-65|4928140365|influenza a virus a/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/maryland/15/2016 bx-69a (a b/colorado/6/2017-like virus) antigen (formaldehyde inactivated)|FLUZONE High-Dose 49281-0403-88|49281040388|49281-403-88|4928140388|influenza a virus a/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/maryland/15/2016 bx-69a (a b/colorado/6/2017-like virus) antigen (formaldehyde inactivated)|FLUZONE High-Dose 49281-0405-65|49281040565|49281-405-65|4928140565|influenza a virus a/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/maryland/15/2016 bx-69a (a b/colorado/6/2017-like virus) antigen (formaldehyde inactivated)|FLUZONE High-Dose 49281-0405-88|49281040588|49281-405-88|4928140588|influenza a virus a/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/maryland/15/2016 bx-69a (a b/colorado/6/2017-like virus) antigen (formaldehyde inactivated)|FLUZONE High-Dose 49281-0413-10|49281041310|49281-413-10|4928141310|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0413-50|49281041350|49281-413-50|4928141350|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0413-58|49281041358|49281-413-58|4928141358|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0413-88|49281041388|49281-413-88|4928141388|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0414-10|49281041410|49281-414-10|4928141410|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0414-50|49281041450|49281-414-50|4928141450|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0414-58|49281041458|49281-414-58|4928141458|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0414-88|49281041488|49281-414-88|4928141488|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0415-10|49281041510|49281-415-10|4928141510|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0415-58|49281041558|49281-415-58|4928141558|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0415-88|49281041588|49281-415-88|4928141588|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0416-10|49281041610|49281-416-10|4928141610|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0416-50|49281041650|49281-416-50|4928141650|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0416-58|49281041658|49281-416-58|4928141658|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0416-88|49281041688|49281-416-88|4928141688|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0417-10|49281041710|49281-417-10|4928141710|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0417-50|49281041750|49281-417-50|4928141750|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0417-58|49281041758|49281-417-58|4928141758|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0417-88|49281041788|49281-417-88|4928141788|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0418-10|49281041810|49281-418-10|4928141810|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0418-50|49281041850|49281-418-50|4928141850|INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0418-58|49281041858|49281-418-58|4928141858|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0418-88|49281041888|49281-418-88|4928141888|INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0419-10|49281041910|49281-419-10|4928141910|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0419-50|49281041950|49281-419-50|4928141950|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0419-58|49281041958|49281-419-58|4928141958|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0419-88|49281041988|49281-419-88|4928141988|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0420-10|49281042010|49281-420-10|4928142010|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0420-50|49281042050|49281-420-50|4928142050|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0420-58|49281042058|49281-420-58|4928142058|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0420-88|49281042088|49281-420-88|4928142088|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0421-10|49281042110|49281-421-10|4928142110|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0421-50|49281042150|49281-421-50|4928142150|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0421-58|49281042158|49281-421-58|4928142158|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0421-88|49281042188|49281-421-88|4928142188|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0422-10|49281042210|49281-422-10|4928142210|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0422-50|49281042250|49281-422-50|4928142250|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0422-58|49281042258|49281-422-58|4928142258|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0422-88|49281042288|49281-422-88|4928142288|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0423-50|49281042350|49281-423-50|4928142350|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|Fluzone Quadrivalent Northern Hemisphere 49281-0423-88|49281042388|49281-423-88|4928142388|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|Fluzone Quadrivalent Northern Hemisphere 49281-0487-58|49281048758|49281-487-58|4928148758|Neisseria Meningitidis Group A Capsular Polysaccharide Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Antigen, and Neisseria Meningitidis Group W-135 Capsular Polysaccharide Antigen|MENOMUNE - A/C/Y/W-135 COMBINED 49281-0488-78|49281048878|49281-488-78|4928148878|Neisseria Meningitidis Group A Capsular Polysaccharide Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Antigen, and Neisseria Meningitidis Group W-135 Capsular Polysaccharide Antigen|MENOMUNE - A/C/Y/W-135 COMBINED 49281-0489-01|49281048901|49281-489-01|4928148901|Neisseria Meningitidis Group A Capsular Polysaccharide Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Antigen, and Neisseria Meningitidis Group W-135 Capsular Polysaccharide Antigen|MENOMUNE - A/C/Y/W-135 COMBINED 49281-0489-91|49281048991|49281-489-91|4928148991|Neisseria Meningitidis Group A Capsular Polysaccharide Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Antigen, and Neisseria Meningitidis Group W-135 Capsular Polysaccharide Antigen|MENOMUNE - A/C/Y/W-135 COMBINED 49281-0510-05|49281051005|49281-510-05|4928151005|DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED, INACTIVATED POLIOVIRUS AND HAEMOPHILUS B CONJUGATE (TETANUS TOXOID CONJUGATE) VACCINE|PENTACEL 49281-0511-05|49281051105|49281-511-05|4928151105|DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED, INACTIVATED POLIOVIRUS AND HAEMOPHILUS B CONJUGATE (TETANUS TOXOID CONJUGATE) VACCINE|PENTACEL 49281-0513-00|49281051300|49281-513-00|4928151300|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0513-25|49281051325|49281-513-25|4928151325|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0514-00|49281051400|49281-514-00|4928151400|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0514-25|49281051425|49281-514-25|4928151425|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0516-00|49281051600|49281-516-00|4928151600|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0516-25|49281051625|49281-516-25|4928151625|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0517-00|49281051700|49281-517-00|4928151700|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0517-25|49281051725|49281-517-25|4928151725|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0518-00|49281051800|49281-518-00|4928151800|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0518-25|49281051825|49281-518-25|4928151825|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0519-00|49281051900|49281-519-00|4928151900|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0519-25|49281051925|49281-519-25|4928151925|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0520-00|49281052000|49281-520-00|4928152000|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0520-25|49281052025|49281-520-25|4928152025|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0521-00|49281052100|49281-521-00|4928152100|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0521-25|49281052125|49281-521-25|4928152125|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0544-58|49281054458|49281-544-58|4928154458|DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED, INACTIVATED POLIOVIRUS AND HAEMOPHILUS B CONJUGATE (TETANUS TOXOID CONJUGATE) VACCINE|PENTACEL 49281-0545-03|49281054503|49281-545-03|4928154503|HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|ActHIB 49281-0545-05|49281054505|49281-545-05|4928154505|HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|ActHIB 49281-0545-15|49281054515|49281-545-15|4928154515|HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|ActHIB 49281-0547-58|49281054758|49281-547-58|4928154758|HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|ActHIB 49281-0548-58|49281054858|49281-548-58|4928154858|DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED, INACTIVATED POLIOVIRUS AND HAEMOPHILUS B CONJUGATE (TETANUS TOXOID CONJUGATE) VACCINE|PENTACEL 49281-0560-05|49281056005|49281-560-05|4928156005|DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED, INACTIVATED POLIOVIRUS AND HAEMOPHILUS B CONJUGATE (TETANUS TOXOID CONJUGATE) VACCINE|PENTACEL 49281-0561-01|49281056101|49281-561-01|4928156101|DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED, INACTIVATED POLIOVIRUS AND HAEMOPHILUS B CONJUGATE (TETANUS TOXOID CONJUGATE) VACCINE|PENTACEL 49281-0562-10|49281056210|49281-562-10|4928156210|diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine|QUADRACEL 49281-0562-58|49281056258|49281-562-58|4928156258|diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine|QUADRACEL 49281-0564-10|49281056410|49281-564-10|4928156410|diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine|QUADRACEL 49281-0564-15|49281056415|49281-564-15|4928156415|diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine|QUADRACEL 49281-0564-58|49281056458|49281-564-58|4928156458|diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine|QUADRACEL 49281-0564-88|49281056488|49281-564-88|4928156488|diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine|QUADRACEL 49281-0574-15|49281057415|49281-574-15|4928157415|nirsevimab|BEYFORTUS 49281-0574-88|49281057488|49281-574-88|4928157488|nirsevimab|BEYFORTUS 49281-0575-00|49281057500|49281-575-00|4928157500|nirsevimab|BEYFORTUS 49281-0575-15|49281057515|49281-575-15|4928157515|nirsevimab|BEYFORTUS 49281-0589-05|49281058905|49281-589-05|4928158905|NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN|Menactra 49281-0589-58|49281058958|49281-589-58|4928158958|NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN|Menactra 49281-0590-01|49281059001|49281-590-01|4928159001|NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|MenQuadfi 49281-0590-05|49281059005|49281-590-05|4928159005|NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|MenQuadfi 49281-0590-10|49281059010|49281-590-10|4928159010|NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|MenQuadfi 49281-0590-58|49281059058|49281-590-58|4928159058|NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|MenQuadfi 49281-0605-01|49281060501|49281-605-01|4928160501|Dengue Tetravalent Vaccine, Live|Dengvaxia 49281-0606-58|49281060658|49281-606-58|4928160658|Dengue Tetravalent Vaccine, Live|Dengvaxia 49281-0618-20|49281061820|49281-618-20|4928161820|COV-2 PRES DTM ANTIGEN|ANTIGEN COMPONENT 49281-0618-78|49281061878|49281-618-78|4928161878|COV-2 PRES DTM ANTIGEN|ANTIGEN COMPONENT 49281-0621-15|49281062115|49281-621-15|4928162115|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0621-78|49281062178|49281-621-78|4928162178|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0625-15|49281062515|49281-625-15|4928162515|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0625-78|49281062578|49281-625-78|4928162578|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0627-15|49281062715|49281-627-15|4928162715|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0627-78|49281062778|49281-627-78|4928162778|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT 49281-0629-15|49281062915|49281-629-15|4928162915|INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0629-78|49281062978|49281-629-78|4928162978|INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0631-15|49281063115|49281-631-15|4928163115|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0631-78|49281063178|49281-631-78|4928163178|INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0633-15|49281063315|49281-633-15|4928163315|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0633-78|49281063378|49281-633-78|4928163378|INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0635-15|49281063515|49281-635-15|4928163515|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0635-78|49281063578|49281-635-78|4928163578|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0637-15|49281063715|49281-637-15|4928163715|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0637-78|49281063778|49281-637-78|4928163778|INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE QUADRIVALENT NORTHERN HEMISPHERE 49281-0639-15|49281063915|49281-639-15|4928163915|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|Fluzone Quadrivalent Northern Hemisphere 49281-0639-78|49281063978|49281-639-78|4928163978|INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)|Fluzone Quadrivalent Northern Hemisphere 49281-0640-15|49281064015|49281-640-15|4928164015|INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE ANTIGEN (FORMALDEHYDE INACTIVATED)|INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE 49281-0650-10|49281065010|49281-650-10|4928165010|INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE ANTIGEN (FORMALDEHYDE INACTIVATED)|INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE 49281-0650-25|49281065025|49281-650-25|4928165025|INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE ANTIGEN (FORMALDEHYDE INACTIVATED)|INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE 49281-0650-50|49281065050|49281-650-50|4928165050|INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE ANTIGEN (FORMALDEHYDE INACTIVATED)|INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE 49281-0650-70|49281065070|49281-650-70|4928165070|INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE ANTIGEN (FORMALDEHYDE INACTIVATED)|INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE 49281-0650-90|49281065090|49281-650-90|4928165090|INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE ANTIGEN (FORMALDEHYDE INACTIVATED)|INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE 49281-0703-55|49281070355|49281-703-55|4928170355|Influenza Virus Vaccine a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated)(Suspension for Injection;2011-2012 Formula)|FLUZONE INTRADERMAL 49281-0705-55|49281070555|49281-705-55|4928170555|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TEXAS/6/2011 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0707-48|49281070748|49281-707-48|4928170748|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0707-55|49281070755|49281-707-55|4928170755|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE 49281-0708-40|49281070840|49281-708-40|4928170840|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE INTRADERMAL QUADRIVALENT 49281-0708-48|49281070848|49281-708-48|4928170848|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE INTRADERMAL QUADRIVALENT 49281-0709-48|49281070948|49281-709-48|4928170948|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE Intradermal 49281-0709-55|49281070955|49281-709-55|4928170955|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE Intradermal 49281-0710-40|49281071040|49281-710-40|4928171040|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE INTRADERMAL QUADRIVALENT 49281-0710-48|49281071048|49281-710-48|4928171048|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-179A (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE INTRADERMAL QUADRIVALENT 49281-0712-40|49281071240|49281-712-40|4928171240|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE INTRADERMAL QUADRIVALENT 49281-0712-48|49281071248|49281-712-48|4928171248|INFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/BRISBANE/60/2008 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE INTRADERMAL QUADRIVALENT 49281-0718-10|49281071810|49281-718-10|4928171810|INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/Singapore/INFIMH-16-0019/2016 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/Maryland/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent 49281-0718-88|49281071888|49281-718-88|4928171888|INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/Singapore/INFIMH-16-0019/2016 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/Maryland/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent 49281-0719-10|49281071910|49281-719-10|4928171910|INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/MARYLAND/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent 49281-0719-88|49281071988|49281-719-88|4928171988|INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/MARYLAND/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent 49281-0720-10|49281072010|49281-720-10|4928172010|INFLUENZA A VIRUS A/HAWAII/70/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/MINNESOTA/41/2019 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/WASHINGTON/02/2019 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent Northern Hemisphere 49281-0720-88|49281072088|49281-720-88|4928172088|INFLUENZA A VIRUS A/HAWAII/70/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/MINNESOTA/41/2019 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/WASHINGTON/02/2019 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent Northern Hemisphere 49281-0721-10|49281072110|49281-721-10|4928172110|INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/TASMANIA/503/2020 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/WASHINGTON/02/2019 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent Northern Hemisphere 49281-0721-88|49281072188|49281-721-88|4928172188|INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/TASMANIA/503/2020 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/WASHINGTON/02/2019 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent Northern Hemisphere 49281-0722-10|49281072210|49281-722-10|4928172210|INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent Northern Hemisphere 49281-0722-88|49281072288|49281-722-88|4928172288|INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent Northern Hemisphere 49281-0723-10|49281072310|49281-723-10|4928172310|INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent Northern Hemisphere 49281-0723-88|49281072388|49281-723-88|4928172388|INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN|Flublok Quadrivalent Northern Hemisphere 49281-0790-20|49281079020|49281-790-20|4928179020|SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN|Typhim Vi 49281-0790-38|49281079038|49281-790-38|4928179038|SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN|Typhim Vi 49281-0790-51|49281079051|49281-790-51|4928179051|SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN|Typhim Vi 49281-0790-88|49281079088|49281-790-88|4928179088|SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN|Typhim Vi 49281-0800-83|49281080083|49281-800-83|4928180083|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|TETANUS TOXOID ADSORBED 49281-0820-10|49281082010|49281-820-10|4928182010|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|TETANUS TOXOID ADSORBED 49281-0860-10|49281086010|49281-860-10|4928186010|POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)|IPOL 49281-0860-55|49281086055|49281-860-55|4928186055|POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)|IPOL 49281-0860-78|49281086078|49281-860-78|4928186078|POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)|IPOL 49281-0860-88|49281086088|49281-860-88|4928186088|POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)|IPOL 49281-0913-01|49281091301|49281-913-01|4928191301|YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN|STAMARIL 49281-0915-01|49281091501|49281-915-01|4928191501|YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN|YF-VAX 49281-0915-05|49281091505|49281-915-05|4928191505|YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN|YF-VAX 49281-0915-58|49281091558|49281-915-58|4928191558|YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN|YF-VAX 49281-0915-68|49281091568|49281-915-68|4928191568|YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN|YF-VAX 49281-0933-50|49281093350|49281-933-50|4928193350|INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CALIFORNIA/122/2022 (A/THAILAND/8/2022-LIKE VIRUS (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Southern Hemisphere 49281-0933-88|49281093388|49281-933-88|4928193388|INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CALIFORNIA/122/2022 (A/THAILAND/8/2022-LIKE VIRUS (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUZONE High-Dose Quadrivalent Southern Hemisphere 50090-1502-00|50090150200|50090-1502-0|5009015020|Hepatitis A Vaccine|HAVRIX 50090-1502-09|50090150209|50090-1502-9|5009015029|Hepatitis A Vaccine|HAVRIX 50090-1693-00|50090169300|50090-1693-0|5009016930|POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)|IPOL 50090-1693-09|50090169309|50090-1693-9|5009016939|POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)|IPOL 50090-2062-00|50090206200|50090-2062-0|5009020620|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|TENIVAC 50090-2062-01|50090206201|50090-2062-1|5009020621|CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)|TENIVAC 50090-2883-00|50090288300|50090-2883-0|5009028830|Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed|INFANRIX 50090-2883-09|50090288309|50090-2883-9|5009028839|Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed|INFANRIX 50090-3096-00|50090309600|50090-3096-0|5009030960|Rabies Vaccine|RabAvert 50090-3469-00|50090346900|50090-3469-0|5009034690|Hepatitis B Vaccine (Recombinant) Adjuvanted|HEPLISAV-B 50090-3469-09|50090346909|50090-3469-9|5009034699|Hepatitis B Vaccine (Recombinant) Adjuvanted|HEPLISAV-B 50090-4958-00|50090495800|50090-4958-0|5009049580|Human Papillomavirus 9-valent Vaccine, Recombinant|GARDASIL 9 50090-4958-01|50090495801|50090-4958-1|5009049581|Human Papillomavirus 9-valent Vaccine, Recombinant|GARDASIL 9 50090-5147-00|50090514700|50090-5147-0|5009051470|Zoster Vaccine Recombinant, Adjuvanted|Shingrix 50090-6026-00|50090602600|50090-6026-0|5009060260|Pneumococcal 20-valent Conjugate Vaccine|PREVNAR 20 50090-6026-01|50090602601|50090-6026-1|5009060261|Pneumococcal 20-valent Conjugate Vaccine|PREVNAR 20 50090-6180-00|50090618000|50090-6180-0|5009061800|NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|MENQUADFI 50090-6180-01|50090618001|50090-6180-1|5009061801|NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN|MENQUADFI 50090-7036-00|50090703600|50090-7036-0|5009070360|pneumococcal vaccine polyvalent|PNEUMOVAX 23 50090-7036-01|50090703601|50090-7036-1|5009070361|pneumococcal vaccine polyvalent|PNEUMOVAX 23 50632-0001-01|50632000101|50632-001-01|5063200101|Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen|JYNNEOS 50632-0001-02|50632000102|50632-001-02|5063200102|Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen|JYNNEOS 50632-0001-03|50632000103|50632-001-03|5063200103|Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen|JYNNEOS 50632-0010-01|50632001001|50632-010-01|5063201001|Rabies Vaccine|RabAvert 50632-0013-01|50632001301|50632-013-01|5063201301|Rabies Vaccine|RabAvert 51285-0138-50|51285013850|51285-138-50|5128513850|Adenovirus Type 4 and Type 7 Vaccine, Live|Adenovirus Type 4 and Type 7 Vaccine, Live 51285-0174-02|51285017402|51285-174-02|5128517402|Adenovirus Type 4 and Type 7 Vaccine, Live|Adenovirus Type 4 and Type 7 Vaccine, Live 51285-0175-02|51285017502|51285-175-02|5128517502|Adenovirus Type 4 and Type 7 Vaccine, Live|Adenovirus Type 4 and Type 7 Vaccine, Live 54868-0734-00|54868073400|54868-0734-0|5486807340|Hepatitis B Vaccine (Recombinant)(Suspension for Intramuscular Injection)|ENGERIX-B 54868-0980-00|54868098000|54868-0980-0|5486809800|Measles, Mumps, and Rubella Virus Vaccine Live|M-M-R II 54868-2219-00|54868221900|54868-2219-0|5486822190|HEPATITIS B VACCINE [RECOMBINANT]|RECOMBIVAX HB 54868-2219-01|54868221901|54868-2219-1|5486822191|hepatitis b vaccine (recombinant)|RECOMBIVAX HB 54868-3339-01|54868333901|54868-3339-1|5486833391|Pneumococcal vaccine polyvalent(Sterile, Liquid Vaccine for Intramuscular or SubcutaneousInjection)|PNEUMOVAX 23 54868-3339-09|54868333909|54868-3339-9|5486833399|Pneumococcal vaccine polyvalent(Sterile, Liquid Vaccine for Intramuscular or SubcutaneousInjection)|PNEUMOVAX 23 54868-4320-00|54868432000|54868-4320-0|5486843200|Pneumococcal vaccine polyvalent(Sterile, Liquid Vaccine for Intramuscular or SubcutaneousInjection)|PNEUMOVAX 23 54868-4320-09|54868432009|54868-4320-9|5486843209|Pneumococcal vaccine polyvalent(Sterile, Liquid Vaccine for Intramuscular or SubcutaneousInjection)|PNEUMOVAX 23 54868-6177-00|54868617700|54868-6177-0|5486861770|Influenza Virus a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated) injection, suspension  (2010-2011 Formulation)|FLUZONE 54868-6180-00|54868618000|54868-6180-0|5486861800|influenza a virus a/california/7/2009 x-179a (h1n1) antigen (formaldehyde inactivated), influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated) injection, suspension|FLUZONE 55045-3841-01|55045384101|55045-3841-1|5504538411|Hepatitis A Vaccine|HAVRIX 58160-0723-03|58160072303|58160-723-03|5816072303|Respiratory Syncytial Visus Vaccine Recombinant, Adjuvanted|Arexvy 58160-0726-15|58160072615|58160-726-15|5816072615|Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)|Hiberix 58160-0740-02|58160074002|58160-740-02|5816074002|Rotavirus Vaccine, Live, Oral|Rotarix 58160-0740-21|58160074021|58160-740-21|5816074021|Rotavirus Vaccine, Live, Oral|Rotarix 58160-0801-11|58160080111|58160-801-11|5816080111|Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine|Menhibrix 58160-0804-01|58160080401|58160-804-01|5816080401|Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted(Emulsion for Intramuscular Injection)|Influenza A (H5N1) Monovalent Vaccine, Adjuvanted 58160-0806-01|58160080601|58160-806-01|5816080601|Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)|HIBERIX 58160-0806-05|58160080605|58160-806-05|5816080605|Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)|HIBERIX 58160-0808-15|58160080815|58160-808-15|5816080815|Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted(Emulsion for Intramuscular Injection)|Influenza A (H5N1) Monovalent Vaccine, Adjuvanted 58160-0809-01|58160080901|58160-809-01|5816080901|Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine|MENHIBRIX 58160-0809-05|58160080905|58160-809-05|5816080905|Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine|MENHIBRIX 58160-0810-01|58160081001|58160-810-01|5816081001|Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed|INFANRIX 58160-0810-11|58160081011|58160-810-11|5816081011|Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed|INFANRIX 58160-0810-43|58160081043|58160-810-43|5816081043|Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed|INFANRIX 58160-0810-52|58160081052|58160-810-52|5816081052|Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed|INFANRIX 58160-0811-41|58160081141|58160-811-41|5816081141|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined|PEDIARIX 58160-0811-43|58160081143|58160-811-43|5816081143|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined|PEDIARIX 58160-0811-51|58160081151|58160-811-51|5816081151|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined|PEDIARIX 58160-0811-52|58160081152|58160-811-52|5816081152|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined|PEDIARIX 58160-0812-01|58160081201|58160-812-01|5816081201|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine|KINRIX 58160-0812-11|58160081211|58160-812-11|5816081211|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine|KINRIX 58160-0812-43|58160081243|58160-812-43|5816081243|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine|KINRIX 58160-0812-52|58160081252|58160-812-52|5816081252|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine|KINRIX 58160-0815-01|58160081501|58160-815-01|5816081501|Hepatitis A and Hepatitis B (Recombinant) Vaccine|TWINRIX 58160-0815-05|58160081505|58160-815-05|5816081505|Hepatitis A and Hepatitis B (Recombinant) Vaccine|TWINRIX 58160-0815-11|58160081511|58160-815-11|5816081511|Hepatitis A and Hepatitis B (Recombinant) Vaccine|TWINRIX 58160-0815-34|58160081534|58160-815-34|5816081534|Hepatitis A and Hepatitis B (Recombinant) Vaccine|TWINRIX 58160-0815-41|58160081541|58160-815-41|5816081541|Hepatitis A and Hepatitis B (Recombinant) Vaccine|TWINRIX 58160-0815-43|58160081543|58160-815-43|5816081543|Hepatitis A and Hepatitis B (Recombinant) Vaccine|TWINRIX 58160-0815-46|58160081546|58160-815-46|5816081546|Hepatitis A and Hepatitis B (Recombinant) Vaccine|TWINRIX 58160-0815-48|58160081548|58160-815-48|5816081548|Hepatitis A and Hepatitis B (Recombinant) Vaccine|TWINRIX 58160-0815-52|58160081552|58160-815-52|5816081552|Hepatitis A and Hepatitis B (Recombinant) Vaccine|TWINRIX 58160-0816-01|58160081601|58160-816-01|5816081601|Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)|Hiberix 58160-0816-03|58160081603|58160-816-03|5816081603|Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)|Hiberix 58160-0816-05|58160081605|58160-816-05|5816081605|Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)|Hiberix 58160-0818-11|58160081811|58160-818-11|5816081811|Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)|Hiberix 58160-0819-12|58160081912|58160-819-12|5816081912|Zoster Vaccine Recombinant, Adjuvanted|Shingrix 58160-0820-01|58160082001|58160-820-01|5816082001|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0820-11|58160082011|58160-820-11|5816082011|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0820-43|58160082043|58160-820-43|5816082043|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0820-52|58160082052|58160-820-52|5816082052|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0821-01|58160082101|58160-821-01|5816082101|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0821-05|58160082105|58160-821-05|5816082105|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0821-11|58160082111|58160-821-11|5816082111|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0821-34|58160082134|58160-821-34|5816082134|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0821-43|58160082143|58160-821-43|5816082143|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0821-52|58160082152|58160-821-52|5816082152|Hepatitis B Vaccine (Recombinant)|ENGERIX-B 58160-0823-11|58160082311|58160-823-11|5816082311|Zoster Vaccine Recombinant, Adjuvanted|Shingrix 58160-0824-15|58160082415|58160-824-15|5816082415|Measels, Mumps, and Rubella Vaccine, Live|Priorix 58160-0825-01|58160082501|58160-825-01|5816082501|Hepatitis A Vaccine|HAVRIX 58160-0825-11|58160082511|58160-825-11|5816082511|Hepatitis A Vaccine|HAVRIX 58160-0825-43|58160082543|58160-825-43|5816082543|Hepatitis A Vaccine|HAVRIX 58160-0825-52|58160082552|58160-825-52|5816082552|Hepatitis A Vaccine|HAVRIX 58160-0826-01|58160082601|58160-826-01|5816082601|Hepatitis A Vaccine|HAVRIX 58160-0826-05|58160082605|58160-826-05|5816082605|Hepatitis A Vaccine|HAVRIX 58160-0826-11|58160082611|58160-826-11|5816082611|Hepatitis A Vaccine|HAVRIX 58160-0826-34|58160082634|58160-826-34|5816082634|Hepatitis A Vaccine|HAVRIX 58160-0826-43|58160082643|58160-826-43|5816082643|Hepatitis A Vaccine|HAVRIX 58160-0826-52|58160082652|58160-826-52|5816082652|Hepatitis A Vaccine|HAVRIX 58160-0827-03|58160082703|58160-827-03|5816082703|Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine|Menveo 58160-0827-30|58160082730|58160-827-30|5816082730|Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine|Menveo 58160-0828-01|58160082801|58160-828-01|5816082801|Zoster Vaccine Recombinant, Adjuvanted|Shingrix 58160-0828-03|58160082803|58160-828-03|5816082803|Zoster Vaccine Recombinant, Adjuvanted|Shingrix 58160-0830-05|58160083005|58160-830-05|5816083005|Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant|CERVARIX 58160-0830-34|58160083034|58160-830-34|5816083034|Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant|CERVARIX 58160-0830-43|58160083043|58160-830-43|5816083043|Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant|CERVARIX 58160-0830-52|58160083052|58160-830-52|5816083052|Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant|CERVARIX 58160-0831-03|58160083103|58160-831-03|5816083103|Measels, Mumps, and Rubella Vaccine, Live|Priorix 58160-0842-01|58160084201|58160-842-01|5816084201|Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed|BOOSTRIX 58160-0842-05|58160084205|58160-842-05|5816084205|Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed|BOOSTRIX 58160-0842-11|58160084211|58160-842-11|5816084211|Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed|BOOSTRIX 58160-0842-34|58160084234|58160-842-34|5816084234|Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed|BOOSTRIX 58160-0842-41|58160084241|58160-842-41|5816084241|Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed|BOOSTRIX 58160-0842-43|58160084243|58160-842-43|5816084243|Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed|BOOSTRIX 58160-0842-51|58160084251|58160-842-51|5816084251|Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed|BOOSTRIX 58160-0842-52|58160084252|58160-842-52|5816084252|Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed|BOOSTRIX 58160-0848-11|58160084811|58160-848-11|5816084811|Respiratory Syncytial Visus Vaccine Recombinant, Adjuvanted|Arexvy 58160-0851-01|58160085101|58160-851-01|5816085101|Rotavirus Vaccine, Live, Oral|ROTARIX 58160-0854-52|58160085452|58160-854-52|5816085452|Rotavirus Vaccine, Live, Oral|ROTARIX 58160-0855-01|58160085501|58160-855-01|5816085501|AS03|AS03 58160-0855-19|58160085519|58160-855-19|5816085519|AS03|AS03 58160-0879-41|58160087941|58160-879-41|5816087941|influenza virus vaccine|FLUARIX 58160-0879-52|58160087952|58160-879-52|5816087952|influenza virus vaccine|FLUARIX 58160-0880-41|58160088041|58160-880-41|5816088041|influenza virus vaccine|FLUARIX 58160-0880-52|58160088052|58160-880-52|5816088052|influenza virus vaccine|FLUARIX 58160-0881-41|58160088141|58160-881-41|5816088141|influenza virus vaccine|FLUARIX 58160-0881-52|58160088152|58160-881-52|5816088152|influenza virus vaccine|FLUARIX 58160-0883-41|58160088341|58160-883-41|5816088341|Influenza Virus Solution for Intramuscular Injection (2015-2016 Formulation)|FLUARIX 58160-0883-52|58160088352|58160-883-52|5816088352|Influenza Virus Solution for Intramuscular Injection (2015-2016 Formulation)|FLUARIX 58160-0885-41|58160088541|58160-885-41|5816088541|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0885-52|58160088552|58160-885-52|5816088552|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0887-41|58160088741|58160-887-41|5816088741|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0887-52|58160088752|58160-887-52|5816088752|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0890-41|58160089041|58160-890-41|5816089041|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0890-52|58160089052|58160-890-52|5816089052|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0896-41|58160089641|58160-896-41|5816089641|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0896-52|58160089652|58160-896-52|5816089652|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0898-41|58160089841|58160-898-41|5816089841|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0898-52|58160089852|58160-898-52|5816089852|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0900-41|58160090041|58160-900-41|5816090041|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0900-52|58160090052|58160-900-52|5816090052|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0901-41|58160090141|58160-901-41|5816090141|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0901-52|58160090152|58160-901-52|5816090152|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0903-41|58160090341|58160-903-41|5816090341|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0903-52|58160090352|58160-903-52|5816090352|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0905-41|58160090541|58160-905-41|5816090541|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0905-52|58160090552|58160-905-52|5816090552|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0907-41|58160090741|58160-907-41|5816090741|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0907-52|58160090752|58160-907-52|5816090752|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0909-41|58160090941|58160-909-41|5816090941|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0909-52|58160090952|58160-909-52|5816090952|influenza virus vaccine|FLUARIX QUADRIVALENT 58160-0955-09|58160095509|58160-955-09|5816095509|Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine|Menveo 58160-0958-01|58160095801|58160-958-01|5816095801|Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine|Menveo 58160-0959-01|58160095901|58160-959-01|5816095901|Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine|Menveo 58160-0964-12|58160096412|58160-964-12|5816096412|Rabies Vaccine|RabAvert 58160-0966-01|58160096601|58160-966-01|5816096601|Rabies Vaccine|RabAvert 58160-0966-12|58160096612|58160-966-12|5816096612|Rabavert|Rabies Vaccine 58160-0976-02|58160097602|58160-976-02|5816097602|NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN|Bexsero 58160-0976-06|58160097606|58160-976-06|5816097606|NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN|Bexsero 58160-0976-20|58160097620|58160-976-20|5816097620|NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN|Bexsero 59267-0078-01|59267007801|59267-0078-1|5926700781|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-0078-04|59267007804|59267-0078-4|5926700784|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-0304-01|59267030401|59267-0304-1|5926703041|original and omicron ba.4/ba.5|Pfizer-BioNTech Covid-19 Vaccine, Bivalent 59267-0304-02|59267030402|59267-0304-2|5926703042|original and omicron ba.4/ba.5|Pfizer-BioNTech Covid-19 Vaccine, Bivalent 59267-0565-01|59267056501|59267-0565-1|5926705651|original and omicron ba.4/ba.5|Pfizer-BioNTech Covid-19 Vaccine, Bivalent 59267-0565-02|59267056502|59267-0565-2|5926705652|original and omicron ba.4/ba.5|Pfizer-BioNTech Covid-19 Vaccine, Bivalent 59267-0609-01|59267060901|59267-0609-1|5926706091|original and omicron ba.4/ba.5|Pfizer-BioNTech Covid-19 Vaccine, Bivalent 59267-0609-02|59267060902|59267-0609-2|5926706092|original and omicron ba.4/ba.5|Pfizer-BioNTech Covid-19 Vaccine, Bivalent 59267-1000-01|59267100001|59267-1000-1|5926710001|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1000-02|59267100002|59267-1000-2|5926710002|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1000-03|59267100003|59267-1000-3|5926710003|RNA ingredient BNT-162B2|Pfizer-BioNTech Covid-19 Vaccine 59267-1000-03|59267100003|59267-1000-3|5926710003|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1025-01|59267102501|59267-1025-1|5926710251|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1025-02|59267102502|59267-1025-2|5926710252|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1025-03|59267102503|59267-1025-3|5926710253|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1025-04|59267102504|59267-1025-4|5926710254|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1055-01|59267105501|59267-1055-1|5926710551|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1055-02|59267105502|59267-1055-2|5926710552|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1055-04|59267105504|59267-1055-4|5926710554|BNT162b2|Pfizer-BioNTech Covid-19 Vaccine 59267-1404-01|59267140401|59267-1404-1|5926714041|original and omicron ba.4/ba.5|Pfizer-BioNTech Covid-19 Vaccine, Bivalent 59267-1404-02|59267140402|59267-1404-2|5926714042|original and omicron ba.4/ba.5|Pfizer-BioNTech Covid-19 Vaccine, Bivalent 59267-4315-01|59267431501|59267-4315-1|5926743151|covid-19 vaccine, mrna|Pfizer-BioNTech Covid-19 Vaccine 59267-4315-02|59267431502|59267-4315-2|5926743152|covid-19 vaccine, mrna|Pfizer-BioNTech Covid-19 Vaccine 59267-4331-01|59267433101|59267-4331-1|5926743311|covid-19 vaccine, mrna|Pfizer-BioNTech Covid-19 Vaccine 59267-4331-02|59267433102|59267-4331-2|5926743312|covid-19 vaccine, mrna|Pfizer-BioNTech Covid-19 Vaccine 59676-0580-05|59676058005|59676-580-05|5967658005|JNJ-78436735|Janssen COVID-19 Vaccine 59676-0580-05|59676058005|59676-580-05|5967658005|Ad26.COV2.S|Janssen COVID-19 Vaccine 59676-0580-15|59676058015|59676-580-15|5967658015|JNJ-78436735|Janssen COVID-19 Vaccine 59676-0580-15|59676058015|59676-580-15|5967658015|Ad26.COV2.S|Janssen COVID-19 Vaccine 62195-0051-01|62195005101|62195-051-01|6219505101|Japanese Encephalitis Vaccine, Inactivated, Adsorbed|Ixiaro 62195-0051-10|62195005110|62195-051-10|6219505110|Japanese Encephalitis Vaccine, Inactivated, Adsorbed|Ixiaro 62577-0613-01|62577061301|62577-613-01|6257761301|INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax 62577-0613-11|62577061311|62577-613-11|6257761311|INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax 62577-0614-01|62577061401|62577-614-01|6257761401|INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) and INFLUENZA B VIRUS B/UTAH/9/2014 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax 62577-0614-11|62577061411|62577-614-11|6257761411|INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) and INFLUENZA B VIRUS B/UTAH/9/2014 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax 63361-0243-10|63361024310|63361-243-10|6336124310|diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine|VAXELIS 63361-0243-15|63361024315|63361-243-15|6336124315|diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine|VAXELIS 63361-0243-58|63361024358|63361-243-58|6336124358|diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine|VAXELIS 63361-0243-88|63361024388|63361-243-88|6336124388|diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine|VAXELIS 63361-0245-10|63361024510|63361-245-10|6336124510|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine|VAXELIS 63361-0245-58|63361024558|63361-245-58|6336124558|Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine|VAXELIS 63851-0501-01|63851050101|63851-501-01|6385150101|Rabies Vaccine|RabAvert 63851-0501-02|63851050102|63851-501-02|6385150102|Rabies Vaccine|RabAvert 63851-0511-11|63851051111|63851-511-11|6385151111|Rabies Vaccine|RabAvert 63851-0612-01|63851061201|63851-612-01|6385161201|INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax 63851-0612-11|63851061211|63851-612-11|6385161211|INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), and INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax 63851-0613-01|63851061301|63851-613-01|6385161301|Influenza Vaccine a/brisbane/10/2010 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/texas/50/2012 x-223a (h3n2) antigen (mdck cell derived, propiolactone inactivated) and influenza b virus b/massachusetts/2/2012 antigen (mdck cell derived, propiolactone inactivated)(Suspension for Intramuscular Injection;2014-2015 Formula)|FLUCELVAX 63851-0613-11|63851061311|63851-613-11|6385161311|Influenza Vaccine a/brisbane/10/2010 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/texas/50/2012 x-223a (h3n2) antigen (mdck cell derived, propiolactone inactivated) and influenza b virus b/massachusetts/2/2012 antigen (mdck cell derived, propiolactone inactivated)(Suspension for Intramuscular Injection;2014-2015 Formula)|FLUCELVAX 64678-0211-01|64678021101|64678-211-01|6467821101|BACILLUS ANTHRACIS|BioThrax 64678-0211-05|64678021105|64678-211-05|6467821105|BACILLUS ANTHRACIS|BioThrax 66019-0107-01|66019010701|66019-107-01|6601910701|Influenza Vaccine Live Intranasal (Intranasal Spray;2009-2010 Formula)|FLUMIST 66019-0108-01|66019010801|66019-108-01|6601910801|Influenza Vaccine Live, Intranasal (Intranasal Spray;2010-2011 Formula)|FLUMIST 66019-0108-10|66019010810|66019-108-10|6601910810|Influenza Vaccine Live, Intranasal (Intranasal Spray;2010-2011 Formula)|FLUMIST 66019-0109-01|66019010901|66019-109-01|6601910901|Influenza Vaccine Live, Intranasal (Intranasal Spray;2011-2012 Formula)|FLUMIST 66019-0109-10|66019010910|66019-109-10|6601910910|Influenza Vaccine Live, Intranasal (Intranasal Spray;2011-2012 Formula)|FLUMIST 66019-0110-01|66019011001|66019-110-01|6601911001|Influenza Vaccine Live Intranasal|FluMist 66019-0110-10|66019011010|66019-110-10|6601911010|Influenza Vaccine Live Intranasal|FluMist 66019-0200-01|66019020001|66019-200-01|6601920001|Influenza A (H1N1) 2009 Monovalent Vaccine Live Influenza, Intranasal|Influenza A H1N1 Intranasal 66019-0200-10|66019020010|66019-200-10|6601920010|INFLUENZA A H1N1 2009 MONOVALENT VACCINE LIVE INTRANASAL|Influenza A H1N1 Intranasal 66019-0300-01|66019030001|66019-300-01|6601930001|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0300-10|66019030010|66019-300-10|6601930010|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0301-01|66019030101|66019-301-01|6601930101|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0301-10|66019030110|66019-301-10|6601930110|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0302-01|66019030201|66019-302-01|6601930201|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0302-10|66019030210|66019-302-10|6601930210|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0303-01|66019030301|66019-303-01|6601930301|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0303-10|66019030310|66019-303-10|6601930310|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0304-01|66019030401|66019-304-01|6601930401|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0304-10|66019030410|66019-304-10|6601930410|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0305-01|66019030501|66019-305-01|6601930501|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0305-10|66019030510|66019-305-10|6601930510|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0306-01|66019030601|66019-306-01|6601930601|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0306-10|66019030610|66019-306-10|6601930610|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0307-01|66019030701|66019-307-01|6601930701|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0307-10|66019030710|66019-307-10|6601930710|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0308-01|66019030801|66019-308-01|6601930801|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0308-10|66019030810|66019-308-10|6601930810|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0309-01|66019030901|66019-309-01|6601930901|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0309-10|66019030910|66019-309-10|6601930910|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0310-01|66019031001|66019-310-01|6601931001|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66019-0310-10|66019031010|66019-310-10|6601931010|Influenza Vaccine Live Intranasal|FluMist Quadrivalent 66521-0000-01|66521000001|66521-000-01|6652100001|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) and INFLUENZA B VIRUS B/BRISBANE/9/2014 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUAD 66521-0000-11|66521000011|66521-000-11|6652100011|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 NIB-88 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) and INFLUENZA B VIRUS B/BRISBANE/9/2014 ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUAD 66521-0112-02|66521011202|66521-112-02|6652111202|Influenza Virus Vaccine|Fluvirin 66521-0112-10|66521011210|66521-112-10|6652111210|Influenza Virus Vaccine|Fluvirin 66521-0113-02|66521011302|66521-113-02|6652111302|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/210/2009 X-187 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATE|FLUVIRIN 66521-0113-10|66521011310|66521-113-10|6652111310|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/210/2009 X-187 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATE|FLUVIRIN 66521-0114-02|66521011402|66521-114-02|6652111402|INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/210/2009 X-187 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|FLUVIRIN 66521-0114-10|66521011410|66521-114-10|6652111410|INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/210/2009 X-187 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|FLUVIRIN 66521-0115-02|66521011502|66521-115-02|6652111502|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/HUBEI-WUJIAGANG/158/2009 BX-39 ANTIGEN (PROPIOLACTONE INACTIVATED)|FLUVIRIN 66521-0115-10|66521011510|66521-115-10|6652111510|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/HUBEI-WUJIAGANG/158/2009 BX-39 ANTIGEN (PROPIOLACTONE INACTIVATED)|FLUVIRIN 66521-0116-02|66521011602|66521-116-02|6652111602|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0116-10|66521011610|66521-116-10|6652111610|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0116-11|66521011611|66521-116-11|6652111611|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0116-12|66521011612|66521-116-12|6652111612|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0117-02|66521011702|66521-117-02|6652111702|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0117-10|66521011710|66521-117-10|6652111710|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0117-11|66521011711|66521-117-11|6652111711|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0117-12|66521011712|66521-117-12|6652111712|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TEXAS/50/2012 X-223 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0118-02|66521011802|66521-118-02|6652111802|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013, NIB-88 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 - WILD TYPE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0118-10|66521011810|66521-118-10|6652111810|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013, NIB-88 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 - WILD TYPE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0118-11|66521011811|66521-118-11|6652111811|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013, NIB-88 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 - WILD TYPE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0118-12|66521011812|66521-118-12|6652111812|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013, NIB-88 (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 - WILD TYPE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 66521-0200-02|66521020002|66521-200-02|6652120002|Influenza A (H1N1) 2009 Monovalent Vaccine|Influenza A (H1N1) 2009 Monovalent Vaccine 66521-0200-10|66521020010|66521-200-10|6652120010|Influenza A (H1N1) 2009 Monovalent Vaccine|Influenza A (H1N1) 2009 Monovalent Vaccine 69401-0000-01|69401000001|69401-000-01|6940100001|Salmonella typhi Ty21a|Vivotif 69401-0000-02|69401000002|69401-000-02|6940100002|Salmonella typhi Ty21a|Vivotif 70460-0001-01|70460000101|70460-001-01|7046000101|Cholera Vaccine, Live, Oral|Vaxchora 70460-0002-02|70460000202|70460-002-02|7046000202|Cholera Vaccine, Live, Oral|Vaxchora 70460-0004-01|70460000401|70460-004-01|7046000401|Cholera Vaccine, Live, Oral|Vaxchora 70461-0001-01|70461000101|70461-001-01|7046100101|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014, NYMC-X-263B (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) and INFLUENZA B VIRUS B/BRISBANE/60/2008 - WILD TYPE HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUAD 70461-0001-11|70461000111|70461-001-11|7046100111|INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014, NYMC-X-263B (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) and INFLUENZA B VIRUS B/BRISBANE/60/2008 - WILD TYPE HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUAD 70461-0002-01|70461000201|70461-002-01|7046100201|A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015 (H1N1)pdm09-like virus), A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus), and B/Brisbane/60/2008, wild type (a B/Brisbane/60/2008-like virus)|FLUAD 70461-0002-11|70461000211|70461-002-11|7046100211|A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015 (H1N1)pdm09-like virus), A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus), and B/Brisbane/60/2008, wild type (a B/Brisbane/60/2008-like virus)|FLUAD 70461-0018-03|70461001803|70461-018-03|7046101803|Influenza Vaccine, Adjuvanted|FLUAD 70461-0018-04|70461001804|70461-018-04|7046101804|Influenza Vaccine, Adjuvanted|FLUAD 70461-0019-03|70461001903|70461-019-03|7046101903|Influenza Vaccine, Adjuvanted|FLUAD 70461-0019-04|70461001904|70461-019-04|7046101904|Influenza Vaccine, Adjuvanted|FLUAD 70461-0020-03|70461002003|70461-020-03|7046102003|influenza vaccine, adjuvanted|FLUAD 70461-0020-04|70461002004|70461-020-04|7046102004|influenza vaccine, adjuvanted|FLUAD 70461-0119-02|70461011902|70461-119-02|7046111902|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014, NYMC-X-263B (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED) and INFLUENZA B VIRUS B/BRISBANE/60/2008 - WILD TYPE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 70461-0119-10|70461011910|70461-119-10|7046111910|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014, NYMC-X-263B (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED) and INFLUENZA B VIRUS B/BRISBANE/60/2008 - WILD TYPE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 70461-0119-11|70461011911|70461-119-11|7046111911|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014, NYMC-X-263B (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED) and INFLUENZA B VIRUS B/BRISBANE/60/2008 - WILD TYPE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 70461-0119-12|70461011912|70461-119-12|7046111912|INFLUENZA A VIRUS A/CHRISTCHURCH/16/2010 NIB-74 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014, NYMC-X-263B (H3N2) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED) and INFLUENZA B VIRUS B/BRISBANE/60/2008 - WILD TYPE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)|Fluvirin 70461-0120-02|70461012002|70461-120-02|7046112002|A/Singapore/GP1908/2015 IVR-180 (an A/Michigan/45/2015 (H1N1)pdm09-like virus, A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus), and B/Brisbane/60/2008, wild type (a B/Brisbane/60/2008-like virus)|Fluvirin 70461-0120-03|70461012003|70461-120-03|7046112003|influenza vaccine, adjuvanted|FLUAD QUADRIVALENT 70461-0120-04|70461012004|70461-120-04|7046112004|influenza vaccine, adjuvanted|FLUAD QUADRIVALENT 70461-0120-10|70461012010|70461-120-10|7046112010|A/Singapore/GP1908/2015 IVR-180 (an A/Michigan/45/2015 (H1N1)pdm09-like virus, A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus), and B/Brisbane/60/2008, wild type (a B/Brisbane/60/2008-like virus)|Fluvirin 70461-0120-11|70461012011|70461-120-11|7046112011|A/Singapore/GP1908/2015 IVR-180 (an A/Michigan/45/2015 (H1N1)pdm09-like virus, A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus), and B/Brisbane/60/2008, wild type (a B/Brisbane/60/2008-like virus)|Fluvirin 70461-0120-12|70461012012|70461-120-12|7046112012|A/Singapore/GP1908/2015 IVR-180 (an A/Michigan/45/2015 (H1N1)pdm09-like virus, A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus), and B/Brisbane/60/2008, wild type (a B/Brisbane/60/2008-like virus)|Fluvirin 70461-0121-03|70461012103|70461-121-03|7046112103|influenza vaccine, adjuvanted|FLUAD QUADRIVALENT 70461-0121-04|70461012104|70461-121-04|7046112104|influenza vaccine, adjuvanted|FLUAD QUADRIVALENT 70461-0122-03|70461012203|70461-122-03|7046112203|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUAD QUADRIVALENT 70461-0122-04|70461012204|70461-122-04|7046112204|INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUAD QUADRIVALENT 70461-0123-03|70461012303|70461-123-03|7046112303|INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUAD QUADRIVALENT 70461-0123-04|70461012304|70461-123-04|7046112304|INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED)|FLUAD QUADRIVALENT 70461-0200-01|70461020001|70461-200-01|7046120001|INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/UTAH/9/2014 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) and INFLUENZA B VIRUS B/HONG KONG/259/2010 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0200-11|70461020011|70461-200-11|7046120011|INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/UTAH/9/2014 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) and INFLUENZA B VIRUS B/HONG KONG/259/2010 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0201-01|70461020101|70461-201-01|7046120101|A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015-like virus), A/Singapore/GP2050/2015 (H3N2) (an A/Hong Kong/4801/2014 - like virus), B/Utah/9/2014 (a B/Phuket/3073/2013-like virus), B/Hong Kong/259/2010 (a B/Brisbane/60/08-like virus)|FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) 70461-0201-11|70461020111|70461-201-11|7046120111|A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015-like virus), A/Singapore/GP2050/2015 (H3N2) (an A/Hong Kong/4801/2014 - like virus), B/Utah/9/2014 (a B/Phuket/3073/2013-like virus), B/Hong Kong/259/2010 (a B/Brisbane/60/08-like virus)|FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) 70461-0301-10|70461030110|70461-301-10|7046130110|A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015-like virus), A/Singapore/GP2050/2015 (H3N2) (an A/Hong Kong/4801/2014 - like virus), B/Utah/9/2014 (a B/Phuket/3073/2013-like virus), B/Hong Kong/259/2010 (a B/Brisbane/60/08-like virus)|FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) 70461-0301-12|70461030112|70461-301-12|7046130112|A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015-like virus), A/Singapore/GP2050/2015 (H3N2) (an A/Hong Kong/4801/2014 - like virus), B/Utah/9/2014 (a B/Phuket/3073/2013-like virus), B/Hong Kong/259/2010 (a B/Brisbane/60/08-like virus)|FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) 70461-0318-04|70461031804|70461-318-04|7046131804|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/IOWA/06/2017 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) 70461-0319-03|70461031903|70461-319-03|7046131903|INFLUENZA A VIRUS A/IDAHO/07/2018 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED, INFLUENZA A VIRUS A/INDIANA/08/2018 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/IOWA/06/2017 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0319-04|70461031904|70461-319-04|7046131904|INFLUENZA A VIRUS A/IDAHO/07/2018 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED, INFLUENZA A VIRUS A/INDIANA/08/2018 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/IOWA/06/2017 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0320-03|70461032003|70461-320-03|7046132003|INFLUENZA A VIRUS A/NEBRASKA/14/2019 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/DELAWARE/39/2019 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/DARWIN/7/2019 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0320-04|70461032004|70461-320-04|7046132004|INFLUENZA A VIRUS A/NEBRASKA/14/2019 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/DELAWARE/39/2019 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/DARWIN/7/2019 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0321-03|70461032103|70461-321-03|7046132103|INFLUENZA A VIRUS A/WASHINGTON/19/2020 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/DARWIN/7/2019 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0321-04|70461032104|70461-321-04|7046132104|INFLUENZA A VIRUS A/WASHINGTON/19/2020 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/DARWIN/7/2019 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0322-03|70461032203|70461-322-03|7046132203|INFLUENZA A VIRUS A/Delaware/55/2019 CVR-45 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax Quadrivalent 70461-0322-04|70461032204|70461-322-04|7046132204|INFLUENZA A VIRUS A/Delaware/55/2019 CVR-45 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax Quadrivalent 70461-0323-03|70461032303|70461-323-03|7046132303|INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax Quadrivalent 70461-0323-04|70461032304|70461-323-04|7046132304|INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax Quadrivalent 70461-0418-10|70461041810|70461-418-10|7046141810|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/IOWA/06/2017 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) 70461-0418-11|70461041811|70461-418-11|7046141811|INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/IOWA/06/2017 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) 70461-0419-10|70461041910|70461-419-10|7046141910|INFLUENZA A VIRUS A/IDAHO/07/2018 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED, INFLUENZA A VIRUS A/INDIANA/08/2018 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/IOWA/06/2017 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0419-11|70461041911|70461-419-11|7046141911|INFLUENZA A VIRUS A/IDAHO/07/2018 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED, INFLUENZA A VIRUS A/INDIANA/08/2018 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/IOWA/06/2017 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0420-10|70461042010|70461-420-10|7046142010|INFLUENZA A VIRUS A/NEBRASKA/14/2019 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/DELAWARE/39/2019 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/DARWIN/7/2019 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0420-11|70461042011|70461-420-11|7046142011|INFLUENZA A VIRUS A/NEBRASKA/14/2019 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/DELAWARE/39/2019 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/DARWIN/7/2019 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0421-10|70461042110|70461-421-10|7046142110|INFLUENZA A VIRUS A/WASHINGTON/19/2020 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/DARWIN/7/2019 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0421-11|70461042111|70461-421-11|7046142111|INFLUENZA A VIRUS A/WASHINGTON/19/2020 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/DARWIN/7/2019 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|FLUCELVAX QUADRIVALENT 70461-0422-10|70461042210|70461-422-10|7046142210|INFLUENZA A VIRUS A/Delaware/55/2019 CVR-45 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax Quadrivalent 70461-0422-11|70461042211|70461-422-11|7046142211|INFLUENZA A VIRUS A/Delaware/55/2019 CVR-45 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax Quadrivalent 70461-0423-10|70461042310|70461-423-10|7046142310|INFLUENZA A VIRUS A/Georgia/12/2022 CRV-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, ROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax Quadrivalent 70461-0423-11|70461042311|70461-423-11|7046142311|INFLUENZA A VIRUS A/Georgia/12/2022 CRV-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, ROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)|Flucelvax Quadrivalent 71665-0001-01|71665000101|71665-001-01|7166500101|Anthrax Vaccine Adsorbed, Adjuvanted|CYFENDUS 71665-0001-02|71665000102|71665-001-02|7166500102|Anthrax Vaccine Adsorbed, Adjuvanted|CYFENDUS 71665-0330-01|71665033001|71665-330-01|7166533001|Smallpox (Vaccinia) Vaccine, Live|ACAM2000 71665-0330-02|71665033002|71665-330-02|7166533002|Smallpox (Vaccinia) Vaccine, Live|ACAM2000 75052-0001-01|75052000101|75052-001-01|7505200101|Hepatitis B Vaccine (Recombinant)|PREHEVBRIO 75052-0001-10|75052000110|75052-001-10|7505200110|Hepatitis B Vaccine (Recombinant)|PREHEVBRIO 76420-0482-01|76420048201|76420-482-01|7642048201|influenza a virus a/christchurch/16/2010 nib-74 (h1n1) antigen (propiolactone inactivated), influenza a virus a/victoria/361/2011 ivr-165 (h3n2) antigen (propiolactone inactivated), influenza b virus b/hubei-wujiagang/158/2009 bx-39 antigen (propiolactone inactivated) and Isopropyl Alcohol|Medical Provider Single Use EZ Flu Shot 2013-2014 76420-0483-01|76420048301|76420-483-01|7642048301|influenza a virus a/christchurch/16/2010 nib-74 (h1n1) antigen (propiolactone inactivated), influenza a virus a/victoria/361/2011 ivr-165 (h3n2) antigen (propiolactone inactivated), influenza b virus b/hubei-wujiagang/158/2009 bx-39 antigen (propiolactone inactivated) and Isopropyl Alcohol|Medical Provider Single Use EZ Flu Shot 2013-2014 80631-0100-01|80631010001|80631-100-01|8063110001|nvx-cov2373|NOVAVAX COVID-19 Vaccine, Adjuvanted 80631-0100-10|80631010010|80631-100-10|8063110010|nvx-cov2373|NOVAVAX COVID-19 Vaccine, Adjuvanted 80631-0102-01|80631010201|80631-102-01|8063110201|nvx-cov2373|NOVAVAX COVID-19 Vaccine, Adjuvanted 80631-0102-10|80631010210|80631-102-10|8063110210|nvx-cov2373|NOVAVAX COVID-19 Vaccine, Adjuvanted 80631-0105-01|80631010501|80631-105-01|8063110501|nvx-cov2373|NOVAVAX COVID-19 Vaccine, Adjuvanted 80631-0105-02|80631010502|80631-105-02|8063110502|nvx-cov2373|NOVAVAX COVID-19 Vaccine, Adjuvanted 80777-0100-11|80777010011|80777-100-11|8077710011|COVID-19 Vaccine, mRNA|Spikevax 80777-0100-99|80777010099|80777-100-99|8077710099|COVID-19 Vaccine, mRNA|Spikevax 80777-0102-01|80777010201|80777-102-01|8077710201|COVID-19 Vaccine, mRNA|Spikevax 80777-0102-04|80777010204|80777-102-04|8077710204|COVID-19 Vaccine, mRNA|Spikevax 80777-0102-93|80777010293|80777-102-93|8077710293|COVID-19 Vaccine, mRNA|Spikevax 80777-0102-95|80777010295|80777-102-95|8077710295|COVID-19 Vaccine, mRNA|Spikevax 80777-0102-96|80777010296|80777-102-96|8077710296|COVID-19 Vaccine, mRNA|Spikevax 80777-0273-10|80777027310|80777-273-10|8077727310|CX-024414|Moderna COVID-19 Vaccine 80777-0273-15|80777027315|80777-273-15|8077727315|CX-024414|Moderna COVID-19 Vaccine 80777-0273-98|80777027398|80777-273-98|8077727398|CX-024414|Moderna COVID-19 Vaccine 80777-0273-99|80777027399|80777-273-99|8077727399|CX-024414|Moderna COVID-19 Vaccine 80777-0275-05|80777027505|80777-275-05|8077727505|CX-024414|Moderna COVID-19 Vaccine 80777-0275-99|80777027599|80777-275-99|8077727599|CX-024414|Moderna COVID-19 Vaccine 80777-0277-05|80777027705|80777-277-05|8077727705|CX-024414|Moderna COVID-19 Vaccine 80777-0277-99|80777027799|80777-277-99|8077727799|CX-024414|Moderna COVID-19 Vaccine 80777-0279-05|80777027905|80777-279-05|8077727905|CX-024414|Moderna COVID-19 Vaccine 80777-0279-99|80777027999|80777-279-99|8077727999|CX-024414|Moderna COVID-19 Vaccine 80777-0282-05|80777028205|80777-282-05|8077728205|Moderna COVID-19 Vaccine, Bivalent|Moderna COVID-19 Vaccine, Bivalent 80777-0282-99|80777028299|80777-282-99|8077728299|Moderna COVID-19 Vaccine, Bivalent|Moderna COVID-19 Vaccine, Bivalent 80777-0283-02|80777028302|80777-283-02|8077728302|Moderna COVID-19 Vaccine, Bivalent|Moderna COVID-19 Vaccine, Bivalent 80777-0283-99|80777028399|80777-283-99|8077728399|Moderna COVID-19 Vaccine, Bivalent|Moderna COVID-19 Vaccine, Bivalent 80777-0287-07|80777028707|80777-287-07|8077728707|Moderna COVID-19 Vaccine|Moderna COVID-19 Vaccine 80777-0287-92|80777028792|80777-287-92|8077728792|Moderna COVID-19 Vaccine|Moderna COVID-19 Vaccine